Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia (Q33985127)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Richard C Harvey

object named as

Richard C Harvey

1

0 references

Charles G. Mullighan

object named as

Charles G Mullighan

2

0 references

Stephen P Hunger

16

object named as

Stephen P Hunger

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cheryl L. Willman

18

object named as

Cheryl L Willman

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Malcolm A Smith

10

object named as

Malcolm A Smith

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Bruce M Camitta

14

object named as

Bruce M Camitta

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

13

object named as

W Paul Bowman

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

15

object named as

Gregory H Reaman

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

7

object named as

Huining Kang

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

object named as

Walker Wharton

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

object named as

Fady M Mikhail

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

I-Ming Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Andrew J Carroll

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Wei Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Kevin K Dobbin

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

William L Carroll

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Meenakshi Devidas

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

James R Downing

17

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

4 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5312-5321

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

JAK mutations in high-risk childhood acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Treatment of acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Molecular genetics of acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

5 July 2018

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

COPA--cancer outlier profile analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902132

29 October 2018

Outlier sums for differential gene expression analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular genetics of acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20139093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2009-09-245944

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33985127&oldid=1858785761"